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Abstract
Ginseng is one of the most commonly used herbs that is believed to have a variety of biological activities, including
reducing blood sugar and cholesterol levels, anti-cancer, and anti-diabetes activities. However, little is known about
the molecular mechanisms involved. In this study, we showed that protopanaxadiol (PPD), a metabolite of the
protopanaxadiol group ginsenosides that are the major pharmacological constituents of ginsengs, significantly altered
the expression of genes involved in metabolism, elevated Sestrin2 (Sesn2) expression, activated AMPK, and induced
autophagy. Using CRISPR/CAS9-mediated gene editing and shRNA-mediated gene silencing, we demonstrated that
Sesn2 is required for PPD-induced AMPK activation and autophagy. Interestingly, we showed that PPD-induced Sesn2
expression is mediated redundantly by the GCN2/ATF4 amino acid-sensing pathway and the PERK/ATF4 endoplasmic
reticulum (ER) stress pathway. Our results suggest that ginseng metabolite PPD modulates the metabolism of amino
acids and lipids, leading to the activation of the stress-sensing kinases GCN2 and PERK to induce Sesn2 expression,
which promotes AMPK activation, autophagy, and metabolic health.
Introduction
Autophagy is an evolutionarily conserved self-
digestive process via which cells adapt to nutrient star-
vation and other stress conditions1,2. Defects in autop-
hagy is associated with a number of pathological
conditions, including cancer, infectious diseases, myo-
pathies, and neurodegenerative disorders3,4. Under
normal growth conditions, autophagy is kept at a basal
level mainly for housekeeping purposes such as degra-
dation of long-lived proteins and turnover of damaged
cellular organelles. Under stress conditions such as
nutrient starvation, ER stress, oxidative stress, and
hypoxia, autophagy is induced to provide cells with
additional internal nutrient supplies and promote
cellular survival5–8. The molecular pathway that links
nutrient depletion and stress to autophagy involves the
energy sensor AMP-activated protein kinase (AMPK)
and the mechanistic target of rapamycin complex 1
(mTORC1). AMPK was shown to be associated with
ULK1 (unc-51-like kinase 1) and phosphorylation of
ULK1 by AMPK was required for autophagy initiation9.
In addition, AMPK can also promote autophagy by
inhibition of autophagy-negative regulator mTORC110.
Sestrin2 (Sesn2) is a member of the highly conserved
antioxidant proteins, which is induced by a variety of cel-
lular stress and functions to activate AMPK, inhibit
mTORC1, and suppress reactive oxygen species accumu-
lation11–14. This allows cells to adjust their metabolism to
adapt to different cellular stresses. Consistent with this,
in vivo studies revealed that Sesn2 is important for meta-
bolic homeostasis. Sesn2-deficient mutants showed diverse
age- and obesity-associated metabolic pathologies such as
accumulation of lipid droplets and protein aggregates,
mitochondrial dysfunction, and insulin resistance. These
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pathologies were related to defective autophagy and the
misregulation of AMPK and mTORC1 signaling15–17.
Importantly, restoration of AMPK activation suppressed
the observed defects in Sestrin-deficient fly and mouse
mutants16–18, suggesting activation of AMPK is a key
in vivo function of Sesn2. In addition, Sesn2 can serve as a
Leu sensor and regulate mTORC1 activity directly through
modulation of GATOR complexes19.
In response to different environmental stresses, the α-
subunit of eukaryotic initiation factor 2 (eIF2α) is phos-
phorylated by distinct kinases, which represses global
translation initiation but selectively enhances the trans-
lation of ATF4, a master regulator controlling the tran-
scription of downstream target genes essential for
adaptive responses, including genes involved in metabo-
lism, cell survival, apoptosis, and autophagy20–22. In
mammals, four protein kinases, GCN2, PERK, HRI, and
PKR, are known to phosphorylate eIF2α in response to
distinct upstream stress signals to modulate translation
initiation. The GCN2 kinase, which is activated by binding
to the uncharged tRNA, phosphorylates eIF2α in response
to amino acid deprivation, whereas PERK, which is a
transmembrane protein of the ER, phosphorylates eIF2α
in response to ER stress21,23.
Ginseng is one of the most commonly used herbs with
a variety of biological activities. Evaluation of randomized
controlled trials revealed that Panax ginseng showed
promising results for improving glucose metabolism,
reducing inflammation, and preventing cancer recur-
rence24. However, little is known of how ginseng may
exert its various effects. It is generally accepted that the
major pharmacological constituents of ginsengs are gin-
senosides with the majority being the protopanaxadiol
(PPD) group ginsenosides25. After oral ingestion, the
bioavailability of ginseng parent compounds is low due to
the low level of absorption. Instead, the parent com-
pounds are transformed by the intestinal microbiome to
the more easily adsorbed metabolites such as compound
K and PPD26–28. We showed previously that PPD sig-
nificantly affected expression of genes involved in lipid
and steroid biosynthesis, and induced ER stress, pro-
death mechanisms such as p53, and pro-survival
mechanisms such as autophagy29. Recent studies sug-
gest that defective autophagy, which is regulated by
AMPK and mTOR, is linked with metabolic diseases such
as obesity, diabetes, and its complications30. In this study,
we characterized the mechanisms by which PPD induces
autophagy.
Materials and methods
PPD source and quality
PPD was synthesized and purified as described26. The
high-performance liquid chromatography-determined
purity was 95.3%.
Cell culture, chemicals, and reagents
Human colorectal cancer cells HCT116 were obtained
from the American Type Culture Collection. Cells were
maintained in Dulbecco’s modified Eagle’s medium sup-
plemented with 5% fetal bovine serum (Hyclone Labora-
tories), 50 IU of penicillin/streptomycin (Gemini Bio-
Products), and 2mmol/l of L-glutamine (Invitrogen) in a
humidified atmosphere with 5% CO2 at 37 °C. The p53
−/−
HCT116 cells were described previously31,32. PERK+/+
and PERK−/− mouse embryonic fibroblasts (MEFs) were
described previously33,34. NAC (N-acetylcysteine) was
obtained from Sigma.
Western blot analysis
After being treated for the desired period of time,
HCT116 cells were collected and washed twice with
phosphate-buffered saline and lysed in RIPA buffer (20
mM Tris-HCl, 150mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% NP-40, 1% sodium deoxycholate, 1 mM phe-
nylmethlsulfonyl fluoride, 2.5 mM sodium pyrophosphate,
1 mM β-glycerophosphate, 1 mM sodium vanadate, 1 µg/
ml leupeptin). Equal amounts of protein were loaded and
the immunoblotting was detected by Li-Cor Odyssey
image reader as described32. Anti-β-actin antibody was
obtained from Santa Cruz Biotechnology. Antibodies
against LC3-I/II, phospho-AMPKα (Thr172), ACC,
phospho-ACC (Ser79), and PERK were obtained from
Cell Signaling Technology. Anti-Sesn2 antibody was
obtained from Proteintech.
TFEB-GFP nuclear localization analysis
Wild-type (WT) or Sesn2 knockout cells were trans-
fected with TFEB-GFP plasmid (a gift from Shawn Fer-
guson, Addgene plasmid #38119). Forty-eight hours after
transfection, cells were treated with vehicle control or 30
µM PPD for 20 h and the localization of TFEB-GFP were
analyzed by fluorescence microscopy. To determine the
percentage of cells with nuclear TFEB-GFP, the localiza-
tion of randomly selected 20 cells for each treatment
groups were determined and repeated 3 times.
RNA isolation and RT-PCR
Total RNA was extracted with the RNeasy Mini Kit
according to the manufacturer’s instructions (Qiagen).
cDNA was synthesized using M-MLV reverse transcriptase
from Promega. Quantitative real-time PCR was carried out
as described35. Primer pairs used for reverse-transcription
PCR (RT-PCR) are: human Sesn2, 5′-CTCCTG GCGC
CACTACATTG-3′ (sense) and 5′-ACTCAGGGTCACC
ACCAGT-3′ (antisense); human CHOP, 5′-TGGAAGCC
TGGTATGAGGAC-3′ (sense) and 5′-TGTGACCTCTGC
TGGTTCTG-3′ (antisense); human ATF3, 5′-GCAGAG
CTAAGCAGT CGTGG -3′ (sense) and 5′-CGCCT
TGATGGTTCTCTGCT-3′ (antisense); human GAPDH,
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5′-CTCTGACTTCAACAGCGACAC-3′ (sense) and 5′-
CATACCAGGAAATGAGCTTGACAA-3′ (antisense);
mouse Sesn2, 5′-GCACCTTCGCCTCCCAGTGA-3′
(sense) and 5′-GCAGGCTCTCCTGAAGCTGC-3′ (anti-
sense); mouse GAPDH, 5′-GCACAGTCAAGGCCGAG
AAT-3′ (sense) and 5′-GCCTTCTCCATGGTGGTGAA-
3′ (antisense).
Microarray data analysis
The data from six microarrays of control or PPD-
treated samples were obtained and normalized as descri-
bed previously36. The normalized data were analyzed
using ArrayTools Version 4.3, to identify genes sig-
nificantly affected by 20–25 µM of PPD treatment.
Replicates were averaged by geometric mean. Parametric
p-values were computed using t-tests on the logarithms of
gene expression intensities. Genes with significantly
altered expression levels, grouped by Kegg biochemical
pathway annotations and ordered by the smallest p-value
within the pathway group, are shown in Supplementary
Table S1. Significance Analysis of Microarrays was per-
formed with a delta of 0.8 and target false discovery rate of
0.00137. Genes were excluded if <20% of expression data
exhibited a 1.5-fold change from the gene’s median or
>50% of data were missing. A minimum intensity
threshold was set at 10. Genes identified by the analysis
are listed in Supplementary Table S2.
Lentiviral preparation and transduction
The pLKO.1 lentiviral sh-RNA expression system was
used to generate short hairpin RNA (shRNA) constructs
as described previously38. The sequences of shRNA and
SgRNA used in this study included the following: sh-GFP
(5′-ACGTCTATATCATGGCCGACA-3′), sh-Sesn2 (5′-
GGTCCACGTGAACTTGCT GC-3′). Lentiviral packa-
ging was done according to the previously described
protocol39. Briefly, expression plasmids pCMV-dR8.91
and pCMV-VSV-G were co-transfected into 293T cells
using the calcium phosphate method at 20:10:10 μg (for a
10 cm dish). The transfection medium containing calcium
phosphate and plasmid mixture was replaced with fresh
complete medium after incubation for 5 h. Media con-
taining virus was collected 48 h after transfection and then
concentrated using 20% sucrose buffer at 20,000 × g for 4
h. The virus pellet was re-dissolved in the proper amount
of complete growth medium and stocked at −80 °C. Cells
were infected with the viruses at the titer of 100% infec-
tion in the presence of Polybrene (10 μg/ml) for 48 h and
were treated as desired.
The Lenti-Crispr V2 system was used to generate
knockout clones40: Sg-GCN2 (5′-GGAGAGCTACCCGC
AACGAC-3′), Sg-PERK (5′-TGGAGCGCGCCATCAGC
CCG-3′), Sg-ATF4 (5′-AGTGAAGTGGATATCACTGA-
3′), Sg-Sesn2 (5′-GGACTACCTGCGGTTCGCCC-3′),
Sg-AMPKα1 (5′-ATTCGGAGCCTTGATGTGGT-3′),
and Sg-AMPKα2 (5′-ATTCGCAGTTTAGATGTTGT-
3′). To generate HCT116 cells with single-gene knockout,
cells were infected with SgRNA viruses at the titer of
100% infection in the presence of Polybrene (10 μg/ml) for
48 h and then single-cell clones was selected by serial
dilution in 96-well plate. To generate GCN2 and PERK
double mutant clones (DKO GCN2&PERK), sgRNA
against PERK was introduced into a clone of GCN2 single
knockout cells and then single-cell clones was selected by
serial dilution in 96-well plate. The single-cell clones were
confirmed by genomic DNA sequencing or western
blotting.
Results
PPD induces Sesn2 expression, which is required for PPD-
induced autophagy
We examined PPD-induced gene expression alterations
to gain insights into the mechanisms by which PPD may
regulate autophagy. Analysis of microarray expression
profiling data for significantly altered expression of indi-
vidual genes nominated differences in the metabolism of
various amino acids, purine and pyrimidine, propanoate
and butanoate, Glycerophospholipid, in the biosynthesis
of steroids and aminoacyl-tRNA, and in mitogen-
activated protein kinase and Insulin signaling (Supple-
mentary Table S1). Significance analysis of microarrays
for PPD-altered genes identified Sesn2, an important
regulator of metabolic homeostasis, in addition to several
genes involved in amino acid transport and synthesis such
as SLC7A11, SLC6A9, and Asparagine Synthetase (Sup-
plementary Table S2). Sesn2 has been shown to regulate
AMPK and mTOR, which are key regulators of autop-
hagy. Indeed, Sesn2 expression was highly induced by
PPD (Fig. 1a). As Sesn2 is known to regulate AMPK and
autophagy, and we previously showed that PPD induced
autophagy, we determined whether Sesn2 is required for
PPD-induced autophagy by examining the effects of Sesn2
inactivation. PPD treatment significantly increased the
level of LC3-II (Fig. 1c, d, sh-GFP and WT). TFEB is
transcription factor that regulates expression of
autophagy-regulated genes and its nuclear localization
can be used to evaluate autophagic flux41. We used TFEB-
GFP cytoplasmic and nuclear localization to further
analyze autophagy induction by PPD42. TFEB-GFP was
excluded from the nucleus in control-treated WT cells;
PPD treatment induced TFEB-GFP to be present in the
nucleus (Fig. 1f, g, WT), similar to treatment with serum-
free medium that is known to induce autophagy (Sup-
plementary Fig. S1). These results suggest that PPD
induces autophagy in WT HCT116 cells. Interestingly,
inactivation of Sesn2 either by shRNA knockdown
(Fig. 1b) or by CRISPR/CAS9-mediated knockout (Fig. 1e)
significantly inhibited PPD-induced LC3-II accumulation
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(Fig. 1c, d) and blocked PPD-induced presence of TFEB-
GFP in the nucleus (Fig. 1f, g). These results suggested
that PPD-induced Sesn2 is required for its induction of
autophagy.
Sesn2 is required for PPD-induced AMPK activation
Sesn2 is known to regulate AMPK activity43. The
induction of Sesn2 by PPD suggest that PPD may induce
AMPK activation, which can be monitored by phos-
phorylation on AMPKα T17244. Indeed, PPD treatment
significantly increased p-AMPKα levels (Fig. 1h) and sig-
nificantly increased phosphorylation of ACC on Ser79
(Fig. 1i), a key target of AMPK in fatty acid biosynthesis45.
These results show that PPD induces AMPK activation.
Interestingly, PPD also slightly increased levels of AMPKα
(Fig. 1h), which is consistent with the report that Sesn2
also modulates AMPK subunit expression46. Importantly,
knockdown of Sesn2 significantly inhibited PPD-induced
phosphorylation of AMPKα on T172 (Fig. 1j). These
results indicate that Sesn2 is also required for PPD-
induced AMPK activation.
TORC1 and ULK1 kinase complexes are key regulators
of autophagy. As AMPK has been shown to regulate both
TORC1 and ULK1 kinase complexes, we tested whether
AMPK activation is involved in PPD-induced autophagy.
We used CRISPR/CAS9 approach to knock out both
Fig. 1 PPD induces Sestrin2, which is required for the induction of AMPK and autophagy. a HCT116 cells were treated with different
concentrations of PPD for 24 h and then the expression levels of Sestrin2 was determined by RT-PCR. b RT-PCR showing knockdown of Sestrin2
expression by sh-Sestrin2 construct. c HCT116 cells were infected with sh-Sestrin2 constructs or sh-GFP control. The knockdown cells were treated
with 30 µM PPD for 24 h and then the LC3-I/II protein levels were determined by western blottings. d HCT116 cells were infected with sg-Sestrin2 or
sg-control constructs. The pools of Sestrin2 knockout or Control cells were treated with PPD 30 µM for 24 h and then the LC3-I/II protein levels were
determined by western blottings. e Western blotting result data showing that sg-Sestrin2-targeted cells has significantly decreased Sestrin2 protein
levels. f Localization of TFEB-GFP in WT or sg-Sestrin2-targeted cells were analyzed by fluorescence microscopy after treatment with vehicle control
(VC) or 30 µM PPD for 20 h. The white scale bar indicate 50 µm. g The average percentage of cells with nuclear TFEB-GFP from f were quantified. The
average and SD for each treatment groups were shown. h HCT116 cells were treated with PPD 30 µM for 24 h and then the level of total AMPKα and
phosphorylated AMPKα (Thr172) was determined by western blottings. i HCT116 cells were treated with PPD 30 µM for 24 h and then the level of
phosphorylated ACC (Ser79) was determined by western blottings. j HCT116 cells were infected with sh-Sestrin2 or sh-GFP control constructs. The
knockdown cells and were treated with PPD 30 µM for 24 h and then the p-AMPKα (Thr172) protein levels were determined by western blottings. k
Western blotting showing the elimination of the AMPKα protein in Crispr/Cas9-mediated AMPKα knockout cells. l HCT116-WT and HCT116-AMPKα-
knockout cells were treated with PPD 30 µM for 24 h and then the LC3-I/II protein levels were determined by western blottings
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AMPKα1 and AMPKα2. Double knockout (DKO)
AMPKα1/α2, which removed both AMPKα1 and
AMPKα2 proteins (Fig. 1k), significantly decreased PPD-
induced LC3-II accumulation (Fig. 1l). Taken together,
these results suggest that Sesn2 is required for PPD-
induced AMPK activation, which contributes to the
autophagy induction.
PPD-induced Sesn2 expression requires ATF4
Sesn2 has been shown to be induced by different stress
insults, including p53, oxidative stress, and ER stress. To
determine the mechanism by which PPD induces Sesn2,
we examined the effects of inactivating p53, addition of
antioxidant NAC, or inactivation of ATF4, a key tran-
scription factor in the PERK branch of ER stress response.
Knockout of p53 or addition of NAC did not affect
Sesn2 induction by PPD (Fig. 2a, b). These observations
suggest that PPD-induced Sesn2 is not mediated by p53
or oxidative stress. In contrast, knockdown of
ATF4 significantly decreased PPD-induced Sesn2
expression (Fig. 2d, e). In addition, PPD also induced
expression of ATF3 and CHOP (Fig. 2c), two ATF4-
regulated transcription factors regulating the expression
of genes involved in the stress response program21. As
expected, induction of ATF3 and CHOP by PPD was also
significantly inhibited by ATF4 knockdown (Fig. 2d). In
addition, we used CRISPR/CAS9 approach to knock out
ATF4 and generated an ATF4 mutant line with a 2 bp
deletion in the open reading frame (Fig. 2f). Knockout of
ATF4 blocked PPD-induced expression of Sesn2, ATF3,
and CHOP (Fig. 2g, h). Furthermore, inactivation of ATF4
but not addition of NAC inhibited PPD-induced LC3-II
accumulation (Fig. 2i–k). These results suggest that ATF4
is required for PPD-induced Sesn2 expression, which in
turn is required for PPD-induced autophagy.
Inactivation of PERK alone does not inhibit PPD-induced
Sesn2 expression
As ATF4 is activated by PERK during ER stress and as
PPD can induce ER stress and expression of PERK branch
of ER stress targets CHOP and ATF3, we further examine
the effect of inactivating PERK. Two independent PERK
Fig. 2 ATF4 is required for PPD-induced Sestrin2 expression and autophagy. a HCT116 (P53+/+) and HCT116 (P53−/−) cells were treated with
PPD 30 µM for 24 h and then the expression level of Sestrin2 was determined by RT-PCR (two PPD treatment group by same concentration). b
HCT116 cells were treated with PPD 30 µM in the absence or presence of NAC for 24 h and then the expression levels of Sestrin2 was determined by
RT-PCR. c HCT116 cells were treated with PPD 30 µM for 24 h and then the expression levels of ATF3, CHOP, and Sestrin2 were determined by RT-PCR.
d HCT116 cells were infected with sh-ATF4 constructs or sh-GFP control. The knockdown cells were treated with PPD 30 µM for 24 h and then the
expression level of ATF3, CHOP, and Sestrin2 were determined by RT-PCR. e HCT116 cells were infected with sh-ATF4 constructs or sh-GFP control.
The knockdown cells were treated with PPD 30 µM for 24 h and then the expression of Sestrin2 was determined by qRT-PCR. f Genomic sequencing
data showing there are 2 bp insertion in the ATF4 open reading frame. g HCT116 and HCT116-ATF4 KO cells were treated with PPD 30 µM for 24 h
and then the expression of ATF3, CHOP, and Sestrin2 were determined by RT-PCR. h HCT116 and HCT116-ATF4 KO cells were treated with PPD 30 µM
for 24 h and then the expression of Sestrin2 was determined by qRT-PCR. i HCT116 cells were infected with sh-ATF4 constructs or sh-GFP control. The
knockdown cells were treated with PPD 30 µM for 24 h and then the expression level of LC3-I/II were determined by western blotting. j HCT116 and
HCT116-ATF4 KO cells were treated with PPD 30 µM for 24 h and then the expression level LC3-I/II were determined by western blotting. k HCT116
cells were treated with PPD 30 µM in the absence or presence of NAC for 24 h and then the expression level of LC3-I/II were determined by western
blotting
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small deletion lines that caused frame-shift mutations
were generated using CRISPR/CAS9 approach (Fig. 3a).
Both lines eliminated PERK protein (Fig. 3b). However,
knockout PERK did not decrease PPD-induced expression
of Sesn2, CHOP, or ATF3 (Fig. 3c–e). Tunicamycin (Tu),
a well-characterized ER stress-inducing agent, induces ER
stress because of the inhibition of N-linked glycoslylation
and the accumulation of unfolded glycoproteins in the ER.
To make sure that the PERK-knockout cell lines did have
the expected effects on ER stress, we characterize their
effects on Tu-induced ER stress. Tu treatment in
WT cells induced expression of Sesn2, CHOP, and ATF3.
Knockout of PERK significantly inhibited Tu-induced
expression of these genes (Fig. 3f, g). Therefore, the PERK
knockout cells failed to inhibit PPD-induced Sesn2
expression, despite having the expected function of
blocking Tu-induced expression of PERK branch of ER-
stress target genes. Furthermore, PPD-induced similar
levels of Sesn2 expression in matched PERK+/+ and
PERK−/− MEFs, even though Tu-induced Sesn2 was
reduced in the PERK−/− cells (Fig. 3h, i). Taken together,
these results suggest that PPD may induce ATF4 activa-
tion and Sesn2 expression through a pathway in parallel
to PERK.
Both amino acid deprivation and ER stress induce Sesn2
expression through ATF4
ATF4 functions downstream of PERK to activate this
branch of ER-stress-induced target gene expression.
Indeed, ATF4 knockout blocked Tu-induced Sesn2
expression (Fig. 4a). As PPD-induced Sesn2 expression
was inhibited by inactivation of ATF4 but not PERK, we
tested the possibility that PPD may induce another
pathway to activate ATF4. Amino acid deprivation is
known to activate ATF421. Indeed, deprivation of amino
acid Gln induced Sesn2 expression, which was blocked by
ATF4 knockout (Fig. 4b). Furthermore, LC3-II accumu-
lation induced by Gln deprivation was also inhibited by
inactivation of ATF4 or Sesn2 (Fig. 4c, d). These results
show that ATF4 is required for amino acid deprivation
and ER stress-induced Sesn2 expression as well.
GCN2 and PERK redundantly regulate PPD-induced Sesn2
expression
As GCN2 can upregulate ATF4 in response to amino
acid deprivation, we generated GCN2-knockout cells with
CRIPSR/Cas9 approach to characterize the effect of
inactivating GCN2 on PPD-induced Sesn2 expression
(Fig. 4e). Interestingly, inactivation of GCN2 inhibited
Gln-deprivation-induced Sesn2, CHOP, or ATF3 expres-
sion (Fig. 4f) but did not inhibit PPD-induced Sesn2,
CHOP, or ATF3 expression (Fig. 4g). These results sug-
gest that inactivation of GCN2 alone is not sufficient to
block for PPD-induced Sesn2 expression either.
To test the possibility that PPD activates both GCN2
and PERK redundantly to upregulate ATF4, we generated
two independent GCN2 and PERK DKO cell lines from
the GCN2 single knockout cells shown in Fig. 4e. As
Fig. 3 PERK is not necessary for PPD-induced Sestrin2 expression. a Genomic sequencing data showing there are 5 bp and 26 bp deletion in the
PERK open reading frame in two independent PERK knockout clones. b Western blotting showing the elimination of PERK protein in the PERK
knockout cells. c HCT116-WT and HCT116-PERK KO (clone No. 2) cells were treated with PPD 30 µM for 24 h and then the expression level of Sestrin2
was determined by qRT-PCR. d HCT116-WT and HCT116-PERK KO (clone No. 2) were treated with PPD 30 µM for 24 h and then the expression level of
ATF3 and CHOP were determined by RT-PCR. e HCT116-WT and HCT116-PERK KO (clone No. 10) were treated with PPD 30 µM for 24 h and then the
expression level of ATF3, CHOP, and Sestrin2 were determined by RT-PCR. f HCT116-WT and HCT116-PERK KO cells (clone No. 2) were treated with ER
stress inducer Tunicamycin (10 μg/ml) for 20 h and then the expression levels of ATF3, CHOP, and Sestrin2 were determined by RT-PCR. g HCT116-WT
and HCT116-PERK KO cells (clone No. 10) were treated with ER stress inducer Tunicamycin (10 µg/ml) for 20 h and then the expression levels of ATF3,
CHOP, and Sestrin2 were determined by RT-PCR. h PERK+/+ and PERK−/− mouse embryonic fibroblasts (MEFs) were treated with PPD 30 µM for 24 h
and then the expression level of Sestrin2 was determined by qRT-PCR. h PERK+/+ and PERK−/− MEFs were treated with PPD 30 µM for 20 h or
Tunicamycin (10 µg/ml) for 20 h and then the expression level of Sestrin2 was determined by RT-PCR
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expected, both DKO cells reduced PERK protein (Fig. 5a).
Importantly, both DKO cells significantly reduced PPD-
induced expression of Sesn2, CHOP, and ATF3
(Fig. 5b–d). These results suggest that PPD can activate
ATF4 and Sesn2 expression through either GCN2 or
PERK, which functions redundantly downstream of PPD
to upregulate ATF4 (Fig. 5e).
Discussion
Our results showed that Sesn2 is strongly induced by
ginseng metabolite PPD and is required for PPD to acti-
vate AMPK and induce autophagy (Fig. 5e). Expression of
Sesn2 can potentially be induced by a variety of stress
signals. Interestingly, although inactivating GCN2 or
PERK alone can block amino acid deprivation or ER
stress-induced Sesn2 expression, respectively, inactivating
either GCN2 or PERK failed to block PPD-induced Sesn2
expression. In contrast, inactivation of both GCN2 and
PERK together blocked PPD-induced Sesn2 expression.
These results suggest that PPD treatment activate both
GCN2 by causing amino acid deprivation and PERK by
inducing ER stress (Fig. 5e).
As PPD significantly affected expression of genes
involved in amino acid transport, metabolism, and
synthesis of aa-tRNA (Table S1), it is likely to be that PPD
treatment caused deficiency in the level of certain amino
acid and certain aa-tRNA, which induced GCN2 activa-
tion. In addition, PPD also significantly inhibited expres-
sion of genes involved in fatty acid and cholesterol
biosynthesis, and interfered with normal lipid metabolism,
which may induce ER stress and PERK activation directly
through causing lipid disequilibrium47,48. Consistent with
this, we found that PPD-induced ER stress was not sig-
nificantly affected by inhibition of new protein synthesis29.
It is increasingly clear that activation of AMPK, induc-
tion of autophagy, and inhibition of mTORC1 are asso-
ciated with increased metabolic health. Metabolic
syndrome is a disorder in the balance between energy
supply, utilization, and storage, and is linked with obesity,
insulin resistance, development of type 2 diabetes, and
increased risks of developing cardiovascular disease and
many types of cancers49–51. Extensive evidence suggest
that dysregulation of AMPK is associated with these
metabolic disorders, and that modulation of AMPK acti-
vation, either through excise or by pharmacological
AMPK activators, could be used to treat or prevent these
diseases52. AMPK activation reprograms cellular meta-
bolism, induces autophagy, and promotes mitochondria
homeostasis53. Therefore, the observed activation of
AMPK by ginseng metabolite PPD raise the possibility
that ginseng may have beneficial effects to promote
metabolic health. This is consistent with finding from a
Fig. 4 ATF4 is required for ER stress and glutamine deprivation-induced Sestrin2 expression and autophagy. a HCT116-WT and HCT116-ATF4
KO cells were treated with tunicamycin (10 µg/ml) for 20 h and then the expression of Sestrin2 was determined by RT-PCR. b HCT116-WT and
HCT116-ATF4 KO cells were treated with glutamine (GLN) deprivation for 20 h and then the expression of Sestrin2 was determined by RT-PCR. c
HCT116-WT and HCT116-ATF4 KO cells were treated with glutamine (GLN) deprivation for 20 h and then the level of LC3-I/II were determined by
western blotting. d HCT116-WT and HCT116-Sestrin2 KO cells were treated with glutamine (GLN) deprivation for 20 h and then the level of LC3-I/II
were determined by western blotting. e Genomic sequencing data showing there are 8 bp deletion in the GCN2 open reading frame. f HCT116-WT
and HCT116-GCN2 KO cells were treated with glutamine (GLN) deprivation for 20 h and then the expression of ATF3, CHOP, and Sestrin2 were
determined by RT-PCR. g HCT116-WT and HCT116-GCN2 KO cells were treated with PPD 30 µM for 24 h and then the expression of ATF3, CHOP, and
Sestrin2 were determined by RT-PCR
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systematic review of randomized controlled trials that
showed ginseng exhibited promising results for improving
glucose metabolism24. In addition, studies of several gin-
senosides in animal models have also showed that these
compounds can promote metabolic health and modulate
glucose and fat metabolism54–56. Taken together, the
finding that ginseng metabolite PPD induces Sesn2,
AMPK activation, and autophagy provides mechanistic
insights into the beneficial effects of ginseng to promote
metabolic health.
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